Nautilus Biotechnolgy, Inc. (NAUT) Insider Trading Activity

NASDAQ$2.295-0.06 (-2.55%)
Market Cap
$299.32M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
311 of 849
Rank in Industry
178 of 491

NAUT Insider Trading Activity

NAUT Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$71,198
2
67
Sells
$11,750,000
1
33

Related Transactions

Patel Sujal MCEO, President, and Secretary
1
$65,238
0
$0
$65,238
Suzuki KentaroChief Marketing Officer
1
$5,960
0
$0
$5,960
AH Equity Partners Bio II, L.L.C.10 percent owner
0
$0
1
$11.75M
$-11.75M

About Nautilus Biotechnolgy, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to …

Insider Activity of Nautilus Biotechnolgy, Inc.

Over the last 12 months, insiders at Nautilus Biotechnolgy, Inc. have bought $71,198 and sold $11.75M worth of Nautilus Biotechnolgy, Inc. stock.

On average, over the past 5 years, insiders at Nautilus Biotechnolgy, Inc. have bought $1.09M and sold $5.99M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Patel Sujal M (CEO, President, and Secretary) — $65,238. Suzuki Kentaro (Chief Marketing Officer) — $5,960.

The last purchase of 25,000 shares for transaction amount of $65,238 was made by Patel Sujal M (CEO, President, and Secretary) on 2026‑03‑04.

List of Insider Buy and Sell Transactions, Nautilus Biotechnolgy, Inc.

2026-06-02SaleAH Equity Partners Bio II, L.L.C.10 percent owner
5M
3.4501%
$2.35
$11.75M
-36.57%
2026-03-04PurchasePatel Sujal MCEO, President, and Secretary
25,000
0.0197%
$2.61
$65,238
-13.36%
2025-11-06PurchaseSuzuki KentaroChief Marketing Officer
4,000
0.0035%
$1.49
$5,960
+39.07%
2025-09-08PurchasePatel Sujal MCEO, President, and Secretary
83,500
0.0644%
$0.68
$57,031
+185.31%
2025-09-05PurchasePatel Sujal MCEO, President, and Secretary
116,500
0.0941%
$0.67
$78,544
+202.57%
2025-09-04PurchaseMurphy Matthew B.General Counsel
20,000
0.0156%
$0.64
$12,858
+206.84%
2025-05-29PurchaseMowry AnnaCFO and Treasurer
15,000
0.0114%
$0.77
$11,489
+137.62%
2025-05-12PurchaseMallick ParagChief Scientist
1,500
0.0012%
$0.73
$1,098
+129.60%
2025-05-08PurchaseMallick ParagChief Scientist
12,000
0.0097%
$0.73
$8,788
+122.53%
2025-03-20PurchasePatel Sujal MCEO, President, and Secretary
23,933
0.0189%
$1.00
$23,890
-13.48%
2025-03-19PurchasePatel Sujal MCEO, President, and Secretary
53,300
0.0438%
$0.99
$53,028
-9.89%
2024-09-23SaleGodwin Mary E.Senior VP, Operations
47,031
0.0386%
$2.87
$134,744
-66.60%
2024-09-17SaleGodwin Mary E.Senior VP, Operations
35,000
0.0277%
$2.85
$99,869
-65.64%
2024-03-11PurchasePatel Sujal MCEO, President, and Secretary
12,044
0.0113%
$2.84
$34,216
+4.36%
2024-03-08PurchasePatel Sujal MCEO, President, and Secretary
2,430
0.0019%
$2.99
$7,262
-15.44%
2024-03-07PurchasePatel Sujal MCEO, President, and Secretary
18,854
0.0145%
$2.89
$54,424
-14.12%
2024-03-06PurchasePatel Sujal MCEO, President, and Secretary
9,267
0.0075%
$2.70
$25,034
-5.60%
2024-03-05PurchasePatel Sujal MCEO, President, and Secretary
7,405
0.0059%
$2.65
$19,597
-2.87%
2022-09-27PurchaseSankar SubramanianSenior VP, Product Development
5,000
0.004%
$2.03
$10,149
+17.73%
2022-09-26PurchaseSankar SubramanianSenior VP, Product Development
10,000
0.0083%
$2.02
$20,250
+21.94%
Total: 45
*Gray background shows transactions not older than one year

Insider Historical Profitability

5.69%
Patel Sujal MCEO, President, and Secretary
10366721
8.1389%
$24.36M150
+12.97%
Suzuki KentaroChief Marketing Officer
4000
0.0031%
$9,400.0010
Mallick ParagChief Scientist
20493392
16.0894%
$48.16M20
+126.07%
PERCEPTIVE ADVISORS LLCdirector
9111151
7.1532%
$21.41M50
<0.0001%
McIlwain Matthew Sdirector
459075
0.3604%
$1.08M40
<0.0001%
Sankar SubramanianSenior VP, Product Development
91250
0.0716%
$214,437.5040
+13.38%
Mowry AnnaCFO and Treasurer
83000
0.0652%
$195,050.0050
+9.07%
Murphy Matthew B.General Counsel
74140
0.0582%
$174,229.0030
+46.23%
Posard Matthew L.director
50000
0.0393%
$117,500.0020
<0.0001%
Weld Gwen EChief People Officer
30000
0.0236%
$70,500.0010
+19%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

Nautilus Biotechnology, Inc.
(NAUT)
$64,733,831
40
5.69%
$299.32M
$140,595,157
34
17.93%
$301.23M
$109,019,806
28
7.37%
$263.86M
$2,471,510
19
17.33%
$334.18M
$104,171,521
16
20.21%
$275.53M

NAUT Institutional Investors: Active Positions

Increased Positions30+41.1%2M+3.98%
Decreased Positions24-32.88%2M-3.4%
New Positions12New1MNew
Sold Out Positions7Sold Out557,858Sold Out
Total Postitions79+8.22%58M+0.58%

NAUT Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
A16z Capital Management, L.L.C.$33,719.0014.01%17.65M00%2025-09-30
Perceptive Advisors Llc$24,055.009.99%12.59M00%2025-09-30
Cercano Management Llc$13,700.005.69%7.17M00%2025-09-30
Madrona Venture Group, Llc$11,500.004.78%6.02M00%2025-09-30
Vanguard Group Inc$4,645.001.93%2.43M-53,252-2.14%2025-09-30
Comprehensive Financial Management Llc$4,217.001.75%2.21M00%2025-09-30
Amazon Com Inc$2,783.001.16%1.46M00%2025-09-30
Clarius Group, Llc$2,310.000.96%1.21M+149,186+14.07%2025-09-30
Renaissance Technologies Llc$1,925.000.8%1.01M+387,756+62.55%2025-09-30
Millennium Management Llc$1,848.000.77%967,548-89,291-8.45%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.